| Expression pattern: |
UP |
| Associated gene: |
SRSF6, Ago2 |
| Associated microRNA: |
miR-660 |
| Biological function: |
promotes breast cancer cell proliferation and lung metastasis/migration; knockdown suppresses tumour growth and lung metastasis |
| Molecular mechanism: |
acts as a miR-660 sponge and functions as a ceRNA to increase SRSF6 expression |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; In Vivo Animal Model; H&E Staining; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
high levels of circFBXL5 correlated with worse outcome of breast cancer |
| Description: |
circFBXL5 is up-regulated in breast cancer (notably in lung metastatic tissues) and its high expression is associated with worse patient outcome. Functionally, circFBXL5 promotes proliferation and lung metastasis/migration, and mechanistically acts as a ceRNA sponge for miR-660 to increase SRSF6 expression via the circFBXL5/miR-660/SRSF6 axis. |
| Confidence score: |
0.7404 |